Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
Julia S. Johansen(ScienceScope (United Kingdom)), Paul A. Price(Eastern Michigan University), Benny Vittrup Jensen(Gentofte Hospital), Anne Roslind(Herlev Hospital), Dorte Nielsen(Herlev Hospital)
Cited by 364
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.
|Journal of Clinical Investigation|1980|660
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
|Journal of Clinical Oncology|2010|600
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
|Nature Communications|2015|484